Skip to main content

What the FDA labels say about taking them together

Everolimus and sirolimus

Everolimus's FDA label (Zortress) of February 12, 2026 names sirolimus in its contraindications section; the sirolimus labels PlainMeds reads (4) do not name everolimus.

Check it at the source: the everolimus FDA label on DailyMed (effective June 1, 2026, Novartis Pharmaceuticals Corporation); the sirolimus FDA label on DailyMed (effective January 28, 2026, Glenmark Pharmaceuticals Inc., USA).

What does the everolimus label say about sirolimus?

Zortress label (Novartis Pharmaceuticals Corporation, February 12, 2026), contraindications

CONTRAINDICATIONS Hypersensitivity to everolimus, sirolimus, or to components of the drug product

Source: FDA drug label (Zortress, NDA021560), Novartis Pharmaceuticals Corporation, effective February 12, 2026 (SPL set e082a024-7850-400b-a5c2-2a140612562a), via openFDA

Source: FDA drug label (Afinitor), Novartis Pharmaceuticals Corporation, effective June 1, 2026 (SPL set 2150f73a-179b-4afc-b8ce-67c85cc72f04), via openFDA; the full label on DailyMed

What does the sirolimus label say about everolimus?

Sirolimus's label (effective January 28, 2026) and its 3 other brand-application labels do not name everolimus in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (sirolimus), Glenmark Pharmaceuticals Inc., USA, effective January 28, 2026 (SPL set 57fb4d90-3ccb-4a69-af1e-53be83f7a504), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

14Everolimus generic labelers
17Sirolimus generic labelers
EverolimusSirolimus
Labeled forBreast cancer, Seizures and epilepsy, Organ transplant rejectionOrgan transplant rejection
Boxed warningNoYes
Pharmacy cost (NADAC)$26.32 per tablet 10 mg tablet$0.723 per tablet 1 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?